FORT-1: Phase II/III Study of Rogaratinib Versus Chemotherapy in Patients With Locally Advanced or Metastatic Urothelial Carcinoma Selected Based on FGFR1 / 3 mRNA Expression
Sternberg, Cora N, Petrylak, Daniel P, Bellmunt, Joaquim, Nishiyama, Hiroyuki, Necchi, Andrea, Gurney, Howard, Lee, Jae-Lyun, van der Heijden, Michiel S, Rosenbaum, Eli, Penel, Nicolas, Pang, See-Tong, Li, Jian-Ri, García Del Muro, Xavier, Joly, Florence, Pápai, Zsuzsanna, Bao, Weichao, Ellinghaus, Peter, Lu, Chengxing, Sierecki, Mitchell, Coppieters, Sabine, Nakajima, Keiko, Ishida, Tatiane Cristine, Quinn, David I
Published in Journal of clinical oncology (20.01.2023)
Published in Journal of clinical oncology (20.01.2023)
Get full text
Journal Article
Results of a phase Ib study of regorafenib (REG) 80 mg/day plus pembrolizumab (PEMBRO) for first-line treatment of advanced hepatocellular carcinoma (HCC)
Kim, Richard D., Harris, William P., Sung, Max W., Waldschmidt, Dirk Thomas, Cabrera, Roniel, Mueller, Udo, Menezes, Flavia, Ishida, Tatiane, Galle, Peter R., El-Khoueiry, Anthony B.
Published in Journal of clinical oncology (20.01.2021)
Published in Journal of clinical oncology (20.01.2021)
Get full text
Journal Article
Updated results of a phase 1b study of regorafenib (REG) 80 mg/day or 120 mg/day plus pembrolizumab (PEMBRO) for first-line treatment of advanced hepatocellular carcinoma (HCC)
El-Khoueiry, Anthony B., Kim, Richard D., Harris, William Proctor, Sung, Max W., Waldschmidt, Dirk, Cabrera, Roniel, Garosi, Vittorio Luigi, Zebger-Gong, Hong, Brennan, Barbara J., Wang, Ying A., Mueller, Udo, Ishida, Tatiane Cristine, Galle, Peter R.
Published in Journal of clinical oncology (20.05.2021)
Published in Journal of clinical oncology (20.05.2021)
Get full text
Journal Article
Clinical Outcome and Characteristics of Patients with Primary Central Nervous System Lymphomas (PCNSL) in a Brazilian Population
Reis, Diego, Ishida, Tatiane, Lage, Luis A P C, Culler, Hebert F, Costa, Renata O, Zerbini, Maria C, Levy, Debora, Rocha, Vanderson, Pereira, Juliana
Published in Blood (08.12.2017)
Published in Blood (08.12.2017)
Get full text
Journal Article
FORT-1: Phase II/III study of rogaratinib versus chemotherapy (CT) in patients (pts) with locally advanced or metastatic urothelial carcinoma (UC) selected based on FGFR1/3 mRNA expression
Quinn, David I., Petrylak, Daniel Peter, Bellmunt, Joaquim, Necchi, Andrea, Gurney, Howard, Lee, Jae-Lyun, Van Der Heijden, Michiel Simon, Rosenbaum, Eli, Penel, Nicolas, Pang, See-Tong, Li, Jian-Ri, Garcia del Muro, Xavier, Joly, Florence, Papai, Zsuzsanna, Ellinghaus, Peter, Lu, Chengxing, Nakajima, Keiko, Ishida, Tatiane, Nishiyama, Hiroyuki, Sternberg, Cora N.
Published in Journal of clinical oncology (20.02.2020)
Published in Journal of clinical oncology (20.02.2020)
Get full text
Journal Article
Efficacy of Copanlisib Monotherapy in Patients with Relapsed or Refractory Marginal Zone Lymphoma: Subset Analysis from the CHRONOS-1 Trial
Dreyling, Martin, Panayiotidis, Panayiotis, Egyed, Miklos, Follows, George, Mollica, Luigina, Nagler, Arnon, Ozcan, Muhit, Santoro, Armando, Ishida, Tatiane, Lu, Cindy, Hiemeyer, Florian, Garcia-Vargas, Jose, Childs, Barrett H., Zinzani, Pier Luigi
Published in Blood (08.12.2017)
Published in Blood (08.12.2017)
Get full text
Journal Article
Updated Safety and Efficacy from the Copanlisib CHRONOS-1 Trial in Patients with Relapsed or Refractory Indolent B-Cell Lymphoma: Low Incidence of Late-Onset Severe Toxicities
Dreyling, Martin, Santoro, Armando, Mollica, Luigina, Leppa, Sirpa, Follows, George, Lenz, Georg, Kim, Won Seog, Nagler, Arnon, Panayiotidis, Panayiotis, Demeter, Judit, Ozcan, Muhit, Kosinova, Marina, Bouabdallah, Krimo, Morschhauser, Franck, Stevens, Don A, Trevarthen, David, Magagnoli, Massimo, Ishida, Tatiane, Lu, Cindy, Hiemeyer, Florian, Miriyala, Ashok, Garcia-Vargas, Jose, Childs, Barrett H., Zinzani, Pier Luigi
Published in Blood (08.12.2017)
Published in Blood (08.12.2017)
Get full text
Journal Article